Advertising

Rating Card

Unlock Expert's Rating and Top Picks Portfolio

Become a member Or, Sign In
Latest Top Picks

Stock Opinions by Ed Ho

WAIT
Have a great noninvasive product to deal with heart problems. Have a new products in the pipeline. Good potential, but may be fully valued.
misc industrial products
TOP PICK
Not really happy with management. Took a big drop and is an interesting buy now. The drug works. Potential of being in phase three next year. Really cheap.
biotechnology / pharmaceutical
TOP PICK
Biotech world has had a tough time in the last month. This company is progressing well. Will take over the clinical development which is very lucrative for the company. Likes management and their pipeline.
biotechnology / pharmaceutical
TOP PICK
Have about $11/12 million in cash and $23/24 million in sales. Profitable. Trading at half X sales. Cheap. Good management.
consulting
TOP PICK
Have put in new (better) management and have recapitalized the costs.
transportation equip & components
TOP PICK
Disappointed on their 2nd quarter, but they were building and shipping inventory in the first two quarters so results won't show until the 3rd/4th quarters.
other services
BUY
Incredibly good management. Expects them to do $.10/$.12 in earnings this year.
other services
WAIT
Has a great product. Had some accounting issues. Expects they will succeed in the long term. Have to start showing sales. A " show me" company.
biotechnology / pharmaceutical
TOP PICK
Has an interesting pipeline of products. An early stage product is a diabetes treatment.
biotechnology / pharmaceutical
DON'T BUY
Management has done a great job in bringing this company back from the dead. Not sure how much they can grow. Probably fairly valued.
computer software / processing
DON'T BUY
An exceptionally well-run company. Relative to the other printers, it is an expensive stock. Good track record deserves a premium, but prefers a pure cyclical play.
publishing / printing
BUY
Have a good technology and a well-run company. The question is, when do they get approval in the US for their commercialization of their ultraviolet scope.
medical services
TOP PICK
Have proven up 2,000,000 tons of rock which, at $300 a ton makes it a low risk exploration play. Cheap.
other mines
VAGUE
Have had problems doing commercial production of silk fibers.
biotechnology / pharmaceutical
DON'T BUY
Trying to raise finances to move into the US market which could be risky. Fairly valued.
misc consumer products
Showing 1 to 15 of 64 entries